Fisher Asset Management Portfolio holdings
Fisher Asset Management, LLC, operating as Fisher Investments, was founded in 1979 by Ken Fisher and is headquartered in Plano, Texas, following a relocation from Camas, Washington, in 2023. As an independent, fee-only investment adviser, it manages over $275 billion in assets for individual and institutional investors globally as of June 2024, offering tailored portfolio management through its Private Client Group and Institutional Group. Known for its active, top-down investment approach guided by a five-member Investment Policy Committee, the firm emphasizes asset allocation and has expanded internationally with offices in eight countries, including a wholly owned subsidiary, Fisher Investments Europe Limited, in London. With Ken Fisher as executive chairman and co-chief investment officer, succeeded as CEO by Damian Ornani in 2016, Fisher Investments blends a legacy of innovation with a client-first philosophy, recently spinning off its 401(k) Solutions into Fisher Retirement Solutions in 2024.
Top Buys
| 1 |
PepsiCo
PEP
|
+$815M |
| 2 |
UnitedHealth
UNH
|
+$744M |
| 3 |
Broadcom
AVGO
|
+$661M |
| 4 |
Procter & Gamble
PG
|
+$651M |
| 5 |
Exxon Mobil
XOM
|
+$570M |
Top Sells
| 1 |
XYZ
Block, Inc.
XYZ
|
+$746M |
| 2 |
Schlumberger
SLB
|
+$579M |
| 3 |
PayPal
PYPL
|
+$542M |
| 4 |
Uber
UBER
|
+$497M |
| 5 |
Target
TGT
|
+$423M |
Sector Composition
| 1 | Technology | 27.95% |
| 2 | Financials | 10.94% |
| 3 | Healthcare | 9.68% |
| 4 | Consumer Discretionary | 9.44% |
| 5 | Industrials | 7.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
476
iShares ESG Aware MSCI USA ETF
ESGU
$14.3B
| $6.41M | ﹤0.01% |
65,788
+5,652
| +9% | +$551K |
|
477
Synopsys
SNPS
$71.8B
| $6.4M | ﹤0.01% |
14,697
-6,192
| -30% | -$2.7M |
|
478
WNS Holdings
WNS
$3.24B
| $6.39M | ﹤0.01% |
86,640
| – | – |
|
479
Global Net Lease
GNL
$1.81B
| $6.38M | ﹤0.01% |
620,644
+11,571
| +2% | +$119K |
|
480
Montrose Environmental
MEG
$1.02B
| $6.36M | ﹤0.01% |
151,079
-7,111
| -4% | -$300K |
|
481
Marriott International Class A Common Stock
MAR
$71.2B
| $6.36M | ﹤0.01% |
34,624
+4,448
| +15% | +$817K |
|
|
GTHX
482
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $6.33M | ﹤0.01% |
2,543,006
-180,896
| -7% | -$450K |
|
483
Huntsman Corp
HUN
$1.88B
| $6.27M | ﹤0.01% |
232,012
+36,959
| +19% | +$999K |
|
484
Steel Dynamics
STLD
$19.5B
| $6.26M | ﹤0.01% |
57,502
-475
| -0.8% | -$51.7K |
|
485
PTC Therapeutics
PTCT
$4.63B
| $6.23M | ﹤0.01% |
153,302
-3,818
| -2% | -$155K |
|
486
Vicor
VICR
$2.25B
| $6.17M | ﹤0.01% |
114,337
-10,800
| -9% | -$583K |
|
487
F5
FFIV
$18.8B
| $6.06M | ﹤0.01% |
41,420
-36
| -0.1% | -$5.27K |
|
488
Vanguard Total Bond Market
BND
$135B
| $5.95M | ﹤0.01% |
81,807
+1,635
| +2% | +$119K |
|
489
Cooper Companies
COO
$13.5B
| $5.89M | ﹤0.01% |
61,424
-1,112
| -2% | -$107K |
|
490
Trex
TREX
$6.43B
| $5.85M | ﹤0.01% |
89,208
+14,488
| +19% | +$950K |
|
491
Neurocrine Biosciences
NBIX
$14B
| $5.85M | ﹤0.01% |
62,006
-2,136
| -3% | -$201K |
|
492
Pebblebrook Hotel Trust
PEB
$1.36B
| $5.82M | ﹤0.01% |
417,274
-8,826
| -2% | -$123K |
|
493
Ameris Bancorp
ABCB
$5.07B
| $5.76M | ﹤0.01% |
168,305
-8,599
| -5% | -$294K |
|
|
UNIT
494
Uniti Group
UNIT
$1.69B
| $5.73M | ﹤0.01% |
1,241,122
-138,492
| -10% | -$640K |
|
495
DigitalOcean
DOCN
$3.11B
| $5.68M | ﹤0.01% |
141,452
| – | – |
|
496
Ryerson Holding
RYI
$707M
| $5.67M | ﹤0.01% |
130,620
-14,213
| -10% | -$617K |
|
497
Vanguard FTSE Emerging Markets ETF
VWO
$99B
| $5.62M | ﹤0.01% |
137,784
+117,310
| +573% | +$4.79M |
|
498
Trinity Industries
TRN
$2.28B
| $5.59M | ﹤0.01% |
217,235
+34
| +0% | +$874 |
|
499
Morningstar
MORN
$10.6B
| $5.58M | ﹤0.01% |
28,462
+2,661
| +10% | +$522K |
|
500
SPS Commerce
SPSC
$4.18B
| $5.57M | ﹤0.01% |
28,991
+653
| +2% | +$125K |
|